文献速递糖尿病

单基因糖尿病占2007至2012年意大利15个儿童糖尿病中心转诊病例的6.3%

Monogenic Diabetes Accounts for 6.3% of Cases Referred to 15 Italian Pediatric Diabetes Centers During 2007 to 2012.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该回顾性研究分析了2007年1月1日至2012年12月31日转诊至意大利15个儿童糖尿病中心的3781例0至18岁患者的临床记录,旨在确定各糖尿病亚型的相对百分比及病因诊断对治疗的影响。结果显示1型糖尿病占92.4%,单基因糖尿病占6.3%(MODY 5.5%,新生儿糖尿病0.6%,遗传综合征0.2%),2型糖尿病占1%;12例携带HNF1A或KCNJ11基因突变的患者因基因诊断从胰岛素转为磺脲类治疗,基因诊断还助于判断慢性并发症预后和提供遗传咨询。

要点

  • 1型糖尿病占92.4%,单基因糖尿病占6.3%,其中MODY 5.5%、新生儿糖尿病0.6%、遗传综合征0.2%。
  • 12例HNF1A或KCNJ11基因突变患者因基因诊断从胰岛素转为磺脲类治疗。
  • 基因诊断有助于判断慢性并发症预后(如GCK/MODY)并提供遗传咨询。

核心结论

  • 单基因糖尿病在转诊至意大利儿童糖尿病中心的患者中高度流行,占6.3%。
  • 基因诊断指导治疗决策,使12例HNF1A或KCNJ11基因突变患者从胰岛素转为磺脲类治疗。
  • 基因诊断有助于判断慢性糖尿病并发症预后(如GCK/MODY)并提供遗传咨询。

研究设计与样本

  • 回顾性研究,纳入2007年1月1日至2012年12月31日转诊至15个意大利儿童糖尿病中心的3781例0至18岁连续患者,诊断为糖尿病或空腹血糖受损。

主要发现

  • 1型糖尿病占92.4%,为主要病因。
  • 单基因糖尿病占6.3%,其中MODY占5.5%,新生儿糖尿病占0.6%,遗传综合征占0.2%。
  • 2型糖尿病占1%。
  • 12例携带HNF1A或KCNJ11基因突变的患者因基因诊断从胰岛素转为磺脲类治疗。

关键数值与推荐

  • 单基因糖尿病占6.3%(MODY 5.5%,新生儿糖尿病0.6%,遗传综合征0.2%)。
  • 1型糖尿病占92.4%,2型糖尿病占1%。

临床怎么用

  • 基因诊断指导治疗决策,12例HNF1A或KCNJ11基因突变患者从胰岛素转为磺脲类治疗。
  • 基因诊断有助于判断慢性糖尿病并发症预后(如GCK/MODY)并提供遗传咨询。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: An etiologic diagnosis of diabetes can affect the therapeutic strategy and prognosis of chronic complications. OBJECTIVE: The aim of the present study was to establish the relative percentage of different diabetes subtypes in patients attending Italian pediatric diabetes centers and the influence of an etiologic diagnosis on therapy. DESIGN, SETTING, AND PATIENTS: This was a retrospective study. The clinical records of 3781 consecutive patients (age, 0 to 18 years) referred to 15 pediatric diabetes clinics with a diagnosis of diabetes or impaired fasting glucose from January 1, 2007 to December 31, 2012 were examined. The clinical characteristics of the patients at their first referral to the centers, type 1 diabetes-related autoantibodies, molecular genetics records, and C-peptide measurements, if requested for the etiologic diagnosis, were acquired. MAIN OUTCOME MEASURES: The primary outcome was to assess the percentage of each diabetes subtype in our sample. RESULTS: Type 1 diabetes represented the main cause (92.4%) of diabetes in this group of patients, followed by monogenic diabetes, which accounted for 6.3% of cases [maturity onset diabetes of the young (MODY), 5.5%; neonatal diabetes mellitus, 0.6%, genetic syndromes, 0.2%]. A genetic diagnosis prompted the transfer from insulin to sulphonylureas in 12 patients bearing mutations in the HNF1A or KCNJ11 genes. Type 2 diabetes was diagnosed in 1% of the patients. CONCLUSIONS: Monogenic diabetes is highly prevalent in patients referred to Italian pediatric diabetes centers. A genetic diagnosis guided the therapeutic decisions, allowed the formulation of a prognosis regarding chronic diabetic complications for a relevant number of patients (i.e.,GCK/MODY), and helped to provide genetic counseling.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Delvecchio M, Mozzillo E, Salzano G, et al. Monogenic Diabetes Accounts for 6.3% of Cases Referred to 15 Italian Pediatric Diabetes Centers During 2007 to 2012. J Clin Endocrinol Metab. 2017. PMID: 28323911. doi:10.1210/jc.2016-2490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。